AptaBio Therapeutics Inc. (293780.KQ)
KRW 8040.0
(2.03%)
KRW 8040.0
(2.03%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -13 Billion KRW | -81.38% |
| 2022 | -10.09 Billion KRW | 18.15% |
| 2021 | -10.36 Billion KRW | -90.17% |
| 2020 | -3.66 Billion KRW | 17.85% |
| 2019 | -6.2 Billion KRW | -110.47% |
| 2018 | -3.4 Billion KRW | -64.6% |
| 2017 | -2.03 Billion KRW | -114.67% |
| 2016 | -839.01 Million KRW | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -4.11 Billion KRW | -7.57% |
| 2024 Q1 | -2.97 Billion KRW | 1.86% |
| 2023 Q2 | -2.86 Billion KRW | 17.13% |
| 2023 Q3 | -4.08 Billion KRW | -42.38% |
| 2023 Q4 | -5.94 Billion KRW | -45.65% |
| 2023 Q1 | -3.46 Billion KRW | -36.52% |
| 2023 FY | - KRW | -81.38% |
| 2022 FY | - KRW | 18.15% |
| 2022 Q4 | -2.53 Billion KRW | -51.39% |
| 2022 Q3 | -1.67 Billion KRW | 39.41% |
| 2022 Q2 | -2.76 Billion KRW | -77.69% |
| 2022 Q1 | -1.55 Billion KRW | 45.52% |
| 2021 FY | - KRW | -90.17% |
| 2021 Q3 | -2.57 Billion KRW | 21.07% |
| 2021 Q2 | -3.26 Billion KRW | -39.81% |
| 2021 Q1 | -2.33 Billion KRW | -26.69% |
| 2021 Q4 | -2.85 Billion KRW | -10.94% |
| 2020 Q1 | -1.58 Billion KRW | 24.69% |
| 2020 Q4 | -1.84 Billion KRW | -53.97% |
| 2020 FY | - KRW | 17.85% |
| 2020 Q3 | -1.19 Billion KRW | 0.52% |
| 2020 Q2 | -1.2 Billion KRW | 24.1% |
| 2019 Q4 | -2.1 Billion KRW | 13.91% |
| 2019 FY | - KRW | -110.47% |
| 2019 Q3 | -2.44 Billion KRW | -248.18% |
| 2019 Q2 | -701.49 Million KRW | 0.0% |
| 2018 Q4 | -2.37 Billion KRW | -838.19% |
| 2018 Q3 | 322.32 Million KRW | 144.8% |
| 2018 Q2 | -719.47 Million KRW | 0.0% |
| 2018 FY | - KRW | -64.6% |
| 2017 FY | - KRW | -114.67% |
| 2016 FY | - KRW | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | 581.09 Million KRW | 2337.963% |
| CMG Pharmaceutical Co., Ltd. | 5.59 Billion KRW | 332.453% |
| Celltrion Pharm, Inc. | 54.22 Billion KRW | 123.983% |
| Huons Global Co., Ltd. | 151.92 Billion KRW | 108.56% |
| DongKook Pharmaceutical Co., Ltd. | 88.68 Billion KRW | 114.664% |
| Enzychem Lifesciences Corporation | -5.77 Billion KRW | -125.238% |
| Humedix Co., Ltd. | 54.87 Billion KRW | 123.699% |
| Boditech Med Inc. | 36.48 Billion KRW | 135.64% |
| EuBiologics Co., Ltd. | -4.39 Billion KRW | -196.109% |
| FutureChem Co.,Ltd | -591.25 Million KRW | -2099.484% |
| Huons Co., Ltd. | 74.23 Billion KRW | 117.519% |
| BNC Korea Co., Ltd. | 14.17 Billion KRW | 191.766% |